Rebecca Armbruster, DO, MS, FACOI: Chief Medical Officer | Jeanes Hospital
Rebecca Armbruster, DO, MS, FACOI: Chief Medical Officer | Jeanes Hospital
A recent study highlighted in the Annals of Allergy, Asthma & Immunology reveals significant improvements for patients with small airways dysfunction when treated with tezepelumab. Dr. Kartik Shenoy, a professor at the Lewis Katz School of Medicine at Temple University, discussed the study's results with Healio Pulmonology.
The research focuses on the potential benefits that tezepelumab can provide for those suffering from dysfunction in small airways, suggesting it could be a promising option for improving patient outcomes. Dr. Shenoy's insights offer a detailed perspective on these findings and underscore the importance of continued exploration in this area of medicine.
Alerts Sign-up